Trials / Completed
CompletedNCT03405688
Transfusion in Sickle Cell Disease: Screening of Sickle Cell Disease Trait in Blood Donors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 173 (actual)
- Sponsor
- Hanane EL KENZ · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Bearers of the sickle cell allele (S) are currently eligible for blood donations in Belgium. As blood donors are not tested for this allele, their heterozygous status is unknown. However, guidelines recommend to transfuse sickle cell patients with blood that is negative for the 'S' hemoglobin. To the investigator's knowledge, no study has been conducted to evaluate the impact of transfusion with blood originating from heterozygous donors on the transfusion performance and the improvement of clinical status of the sickle cell disease patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood sampling | Extra blood samples taken for laboratory analysis |
Timeline
- Start date
- 2018-02-13
- Primary completion
- 2020-08-03
- Completion
- 2020-08-03
- First posted
- 2018-01-23
- Last updated
- 2021-01-28
Locations
2 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03405688. Inclusion in this directory is not an endorsement.